| scholarly article | Q13442814 |
| P50 | author | Malak Kotb | Q114318924 |
| Sarah Rowe | Q51899708 | ||
| P2093 | author name string | Jenny P-Y Ting | |
| Debra J Taxman | |||
| Arthur Geller | |||
| Engy Mahrous | |||
| Leighton Legros | |||
| Lidia A Gardner | |||
| Ramy R Attia | |||
| P2860 | cites work | Cloning, expression, and functional characterization of the beta regulatory subunit of human methionine adenosyltransferase (MAT II) | Q22011144 |
| Criteria for effective design, construction, and gene knockdown by shRNA vectors | Q25256708 | ||
| A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid | Q26778512 | ||
| S-adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: a new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver | Q28575436 | ||
| Expression and functional interaction of the catalytic and regulatory subunits of human methionine adenosyltransferase in mammalian cells | Q28646397 | ||
| S-adenosylmethionine synthesis: molecular mechanisms and clinical implications | Q28646532 | ||
| Production of high-titer helper-free retroviruses by transient transfection | Q29547802 | ||
| Polyamines | Q29615154 | ||
| In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation. | Q30747325 | ||
| Methionine metabolism in mammals | Q34366989 | ||
| S-Adenosylmethionine and methylation | Q34382111 | ||
| Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells | Q34416761 | ||
| S-Adenosylmethionine: a control switch that regulates liver function. | Q34482345 | ||
| S-adenosylmethionine: jack of all trades and master of everything? | Q34503043 | ||
| S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism | Q34546376 | ||
| Galpha13 mediates a signal that is essential for proliferation and survival of thymocyte progenitors | Q36399540 | ||
| Inborn errors of sulfur-containing amino acid metabolism | Q36479642 | ||
| Expression pattern, regulation, and functions of methionine adenosyltransferase 2beta splicing variants in hepatoma cells | Q36692913 | ||
| Mitotic arrest, apoptosis, and sensitization to chemotherapy of melanomas by methionine deprivation stress. | Q54587527 | ||
| Synergistic effect of methionine-depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: a randomized, prospective clinical trial. | Q54979956 | ||
| S-Adenosylmethionine; a new intermediate formed enzymatically from L-methionine and adenosinetriphosphate. | Q55036879 | ||
| Influence of oral S-adenosylmethionine on plasma 5-methyltetrahydrofolate, S-adenosylhomocysteine, homocysteine and methionine in healthy humans | Q56832817 | ||
| Inhibitors of ATP: L-methionine S-adenosyltransferase—L-Methionine analogues | Q66920821 | ||
| Structural and conformational analogues of L-methionine as inhibitors of the enzymatic synthesis of S-adenosyl-L-methionine. IV. Further mono-, bi- and tricyclic amino acids | Q66946828 | ||
| Antigenic conservation of primary structural regions of S-adenosylmethionine synthetase | Q67670885 | ||
| Toward the synthesis of isozyme-specific enzyme inhibitors. Potent inhibitors of rat methionine adenosyltransferases. Effect of one-atom elongation of the ribose-P alpha bridge in two covalent adducts of L-methionine and beta,gamma-imido-ATP | Q68090719 | ||
| Structural and conformational analogues of L-methionine as inhibitors of the enzymatic synthesis of S-adenosyl-l-methionine. 3. Carbocyclic and heterocyclic amino acids | Q69823815 | ||
| S-Adenosylmethionine synthetase from human lymphocytes. Purification and characterization | Q70073689 | ||
| Fractionation of methionine adenosyltransferase isozymes (rat liver) | Q71048050 | ||
| Chemotherapeutic potential of methionine analogue inhibitors of tumor-derived methionine adenosyltransferases | Q71725878 | ||
| Differential regulation of methionine adenosyltransferase in superantigen and mitogen stimulated human T lymphocytes | Q73427558 | ||
| A method for the rapid construction of cRNA standard curves in quantitative real-time reverse transcription polymerase chain reaction | Q74177660 | ||
| A new series of S-adenosyl-L-methionine synthetase inhibitors | Q77481967 | ||
| Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult t-cell leukemia | Q80458847 | ||
| Methionine restriction decreases mitochondrial oxygen radical generation and leak as well as oxidative damage to mitochondrial DNA and proteins | Q83978389 | ||
| New therapeutic strategies for the treatment of acute lymphoblastic leukaemia | Q36724661 | ||
| Pharmacogenetics of acute lymphoblastic leukemia treatment response | Q36968156 | ||
| CIITA-regulated plexin-A1 affects T-cell-dendritic cell interactions. | Q38351580 | ||
| Methionine Adenosyltransferase ( S ‐Adenosylmethionine Synthetase) and S ‐Adenosylmethionine Decarboxylase | Q40169467 | ||
| Methionine adenosyltransferase: structure and function | Q40799580 | ||
| Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo | Q41059815 | ||
| Differential kinetic properties of L-2-amino-4-methylthio-cis-but-3-enoic acid, a methionine analog inhibitor of S-adenosylmethionine synthetase | Q41528539 | ||
| Induction of interleukin 2 production but not methionine adenosyltransferase activity or S-adenosylmethionine turnover in Jurkat T-cells | Q41618528 | ||
| Methionine dependency of malignant tumors: a possible approach for therapy | Q41717912 | ||
| Approaches to isozyme-specific inhibitors. 16. A novel methyl-C5' covalent adduct of L-ethionine and beta,gamma-imido-ATP as a potent multisubstrate inhibitor of rat methionine adenosyltransferases | Q42199282 | ||
| Changes in the relative amount of subunits of methionine adenosyltransferase in human lymphocytes upon stimulation with a polyclonal T cell mitogen | Q43589260 | ||
| Methionine adenosyltransferase II beta subunit gene expression provides a proliferative advantage in human hepatoma | Q44387828 | ||
| Isozymes of S-adenosylmethionine synthetase from rat liver: isolation and characterization | Q44887169 | ||
| Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products | Q48777148 | ||
| P433 | issue | 45 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| cell growth | Q189159 | ||
| gene silencing | Q1431332 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 30788-30795 | |
| P577 | publication date | 2008-08-27 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Selective targeting of leukemic cell growth in vivo and in vitro using a gene silencing approach to diminish S-adenosylmethionine synthesis | |
| P478 | volume | 283 |
| Q39162217 | Anti-leukemic response of a NSAID, tolfenamic acid. |
| Q36646416 | Crystallography captures catalytic steps in human methionine adenosyltransferase enzymes. |
| Q36556335 | Downregulation of Cdc6 and pre-replication complexes in response to methionine stress in breast cancer cells |
| Q34170057 | Efficient induction of extrinsic cell death by dandelion root extract in human chronic myelomonocytic leukemia (CMML) cells |
| Q40873454 | MAT2B promotes adipogenesis by modulating SAMe levels and activating AKT/ERK pathway during porcine intramuscular preadipocyte differentiation |
| Q97570182 | Neurodegeneration in multiple sclerosis involves multiple pathogenic mechanisms |
| Q34027272 | Proteomic profile of pre - B2 lymphoblasts from children with acute lymphoblastic leukemia (ALL) in relation with the translocation (12; 21) |
| Q37418460 | S-adenosylmethionine limitation induces p38 mitogen-activated protein kinase and triggers cell cycle arrest in G1. |
| Q27684874 | Structure and function study of the complex that synthesizesS-adenosylmethionine |
| Q38214772 | Targeted nanoparticles for pediatric leukemia therapy |
| Q38758640 | Targeting S-adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A. |
Search more.